Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
ir.gemphire.com/...54241&p=irol-newsArticle&ID=2363275
www.fiercebiotech.com/biotech/...ne-fatty-liver-disease-trial
Werbung
| Strategie | Hebel | |||
| Steigender Gold-Kurs | 5,01 | 10,01 | 15,19 | |
| Fallender Gold-Kurs | 4,99 | 10,01 | 15,12 | |
|
Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
ir.gemphire.com/...54241&p=irol-newsArticle&ID=2363275
www.fiercebiotech.com/biotech/...ne-fatty-liver-disease-trial
kritischer Kommentar von AF
twitter.com/adamfeuerstein/status/1143860778090582017
Merger mit NeuroBo Pharmaceuticals
ir.gemphire.com/news-releases/...robo-pharmaceuticals-announce
Werbung
| Strategie | Hebel | |||
| Steigender Gold-Kurs | 5,01 | 10,01 | 15,19 | |
| Fallender Gold-Kurs | 4,99 | 10,01 | 15,12 | |
| Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
| 4 | GEMP 1,58$ (-52%) | Vassago | Vassago | 25.04.21 02:50 |